ArticleScientific reports2025
A comprehensive feature importance analysis of surgical site infection following colorectal cancer surgery.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Risks and outcomes of surgical site infection after minimally invasive colorectal surgery: a Japanese multicenter study.Surgery today · 2026Observational
- Ten-Year Outcomes in Colorectal Cancer-Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study.Journal of clinical medicine · 2026Article
- The Predictive Value of Clinical and Systemic Inflammatory Biomarkers in Emergency Colic Cancer Surgery: A Retrospective Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surgical site infection (SSI) after colorectal cancer (CRC) surgery is still a significant healthcare issue. This study aimed to analyze risk factor associated with SSI. A total of 528 consecutive CRC patients who underwent curative resections between September 2017 and August 2024 were analyzed. Receiver operating characteristic (ROC) curves and machine learning (ML) models of Random Forest, K-Nearest Neighbor, Decision Tree, and XG Boost were employed for risk factor evaluation. SSI rate was 17.6%. SSI development varied significantly by tumor location, surgical technique, stoma formation, and neoadjuvant therapy. Furthermore, the preoperative values of white blood cell (WBC) count ≤ 5 (10
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.